| 國立成功大學 |
2023 |
2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
|
Huang, W.-C.;Hsieh, S.-C.;Wu, Y.-W.;Hsieh, T.-Y.;Wu, Y.-J.;Li, K.-J.;Charng, M.-J.;Chen, W.-S.;Sung, Sung S.-H.;Tsao, Y.-P.;Ho, W.-J.;Lai, C.-C.;Cheng, Cheng C.-C.;Tsai, H.-C.;Hsu, C.-H.;Lu, C.-H.;Chiu, Y.-W.;Shen, C.-Y.;Wu, C.-H.;Liu, F.-C.;Lin, Y.-H.;Yeh, F.-C.;Liu, W.-S.;Lee, H.-T.;Wu, S.-H.;Chang, Chang C.-C.;Chu, Chu C.-Y.;Hou, C.J.-Y.;Tsai, C.-Y. |
| 臺大學術典藏 |
2022-09-06T02:46:05Z |
Validation of the Chinese Version of the Autism Diagnostic Interview-Revised in Autism Spectrum Disorder
|
Huang C.-F.; Lin Y.-S.; YEN-NAN CHIU; Gau S.S.-F.; Chen V.C.-H.; Lin C.-F.; Hsieh Y.-H.; Liu W.-S.; Chan H.-L.; Wu Y.-Y. |
| 臺大學術典藏 |
2022-08-23T02:35:04Z |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu L.-S.; Wu Y.-W.; Chang J.T.-C.; Chang W.-T.; Chao T.-H.; Chen H.H.-W.; Chen Y.-J.; Cheng K.-H.; Hsu W.-L.; Hung C.-L.; SUNG-HSIN KUO; Liang J.-A.; Lin H.-J.; Liu P.-Y.; Liu W.-S.; Liu Y.-W.; Shueng P.-W.; Wang C.-Y.; Hou C.J.-Y.; Chiou J.-F.; TASTRO-TSOC Cardio-Oncology Task Force |
| 國立成功大學 |
2022 |
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)
|
Lu, Lu L.-S.;Wu, Y.-W.;Chang, J.T.-C.;Chang, W.-T.;Chao, T.-H.;Chen, H.H.-W.;Chen, Y.-J.;Cheng, K.-H.;Hsu, W.-L.;Hung, C.-L.;Kuo, S.-H.;Liang, J.-A.;Lin, H.-J.;Liu, P.-Y.;Liu, W.-S.;Liu, Y.-W.;Shueng, P.-W.;Wang, C.-Y.;Hou, C.J.-Y.;Chiou, J.-F.;Force, TASTRO-TSOC Cardio-Oncology Task |
| 臺大學術典藏 |
2021-03-18T05:59:02Z |
Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector
|
Lee N.-C.; Chien Y.-H.; Hu M.-H.; Liu W.-S.; Chen P.-W.; Wang W.-H.; KAI-YUAN TZEN; Byrne B.J.; Hwu W.-L. |
| 臺大學術典藏 |
2021-03-18T05:59:00Z |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency
|
Lee N.-C.; Muramatsu S.-I.; Chien Y.-H.; Liu W.-S.; Wang W.-H.; Cheng C.-H.; Hu M.-K.; Chen P.-W.; KAI-YUAN TZEN; Byrne B.J.; Hwu W.-L. |
| 臺大學術典藏 |
2021-03-13T03:29:24Z |
Is severity a clinically meaningful specifier of somatic symptom disorder?
|
Tu C.-Y.;Liu W.-S.;Yen-Fu Chen;Huang W.-L.; Tu C.-Y.; Liu W.-S.; YEN-FU CHEN; Huang W.-L. |
| 臺大學術典藏 |
2020-12-24T06:16:39Z |
Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector
|
Lee N.-C.; YIN-HSIU CHIEN; Hu M.-H.; Liu W.-S.; Chen P.-W.; Wang W.-H.; Tzen K.-Y.; Byrne B.J.; Hwu W.-L. |
| 臺大學術典藏 |
2020-12-16T02:25:25Z |
Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector
|
Lee N.-C.; Chien Y.-H.; Hu M.-H.; Liu W.-S.; Chen P.-W.; Wang W.-H.; Tzen K.-Y.; Byrne B.J.; WUH-LIANG HWU |
| 臺大學術典藏 |
2020-12-16T02:25:22Z |
Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency
|
Lee N.-C.; Muramatsu S.-I.; Chien Y.-H.; Liu W.-S.; Wang W.-H.; Cheng C.-H.; Hu M.-K.; Chen P.-W.; Tzen K.-Y.; Byrne B.J.; WUH-LIANG HWU |
